U.S. Physical Therapy, Inc. $USPH Shares Bought by Northern Trust Corp

Northern Trust Corp raised its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 4.7% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 274,117 shares of the company’s stock after purchasing an additional 12,292 shares during the quarter. Northern Trust Corp owned about 1.80% of U.S. Physical Therapy worth $19,835,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. GAMMA Investing LLC boosted its holdings in shares of U.S. Physical Therapy by 27,856.8% in the 1st quarter. GAMMA Investing LLC now owns 12,301 shares of the company’s stock valued at $890,000 after purchasing an additional 12,257 shares during the last quarter. Lazard Asset Management LLC acquired a new position in shares of U.S. Physical Therapy in the 4th quarter valued at $84,000. Deutsche Bank AG boosted its holdings in shares of U.S. Physical Therapy by 49.3% in the 4th quarter. Deutsche Bank AG now owns 13,176 shares of the company’s stock valued at $1,169,000 after purchasing an additional 4,350 shares during the last quarter. Principal Financial Group Inc. boosted its holdings in shares of U.S. Physical Therapy by 2.3% in the 1st quarter. Principal Financial Group Inc. now owns 84,964 shares of the company’s stock valued at $6,148,000 after purchasing an additional 1,873 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of U.S. Physical Therapy by 35.6% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 35,761 shares of the company’s stock valued at $3,172,000 after purchasing an additional 9,395 shares during the last quarter.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 698 shares of the business’s stock in a transaction on Monday, August 25th. The shares were sold at an average price of $86.11, for a total value of $60,104.78. Following the transaction, the chief financial officer owned 27,808 shares in the company, valued at $2,394,546.88. The trade was a 2.45% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Nancy Ham sold 400 shares of the business’s stock in a transaction on Thursday, June 12th. The stock was sold at an average price of $78.01, for a total transaction of $31,204.00. Following the completion of the transaction, the director owned 2,594 shares in the company, valued at $202,357.94. This represents a 13.36% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 3,653 shares of company stock worth $311,274. 2.00% of the stock is currently owned by corporate insiders.

U.S. Physical Therapy Stock Performance

NYSE:USPH opened at $82.89 on Tuesday. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.30. The firm has a market capitalization of $1.26 billion, a price-to-earnings ratio of 36.20, a PEG ratio of 4.15 and a beta of 1.47. The firm’s fifty day simple moving average is $79.33 and its 200 day simple moving average is $76.63. U.S. Physical Therapy, Inc. has a twelve month low of $62.77 and a twelve month high of $101.19.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.10. The business had revenue of $197.34 million for the quarter, compared to analyst estimates of $190.24 million. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The business’s quarterly revenue was up 18.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.73 EPS. As a group, equities research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 12th. Investors of record on Friday, August 22nd will be issued a dividend of $0.45 per share. The ex-dividend date is Friday, August 22nd. This represents a $1.80 annualized dividend and a dividend yield of 2.2%. U.S. Physical Therapy’s payout ratio is presently 78.60%.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on USPH. Wall Street Zen upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Thursday, May 8th. Barrington Research lifted their price target on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the company an “outperform” rating in a report on Friday, August 8th. Finally, Zacks Research upgraded shares of U.S. Physical Therapy to a “hold” rating in a report on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $110.25.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.